A randomized study of neuroimmunotherapy with low-dose subcutaneous interleukin-2 plus melatonin compared to supportive care alone in patients with untreatable metastatic solid tumour
P. Lissoni, S. Barni, V. Fossati, A. Ardizzoia, M. Cazzaniga, G. Tancini, F. FrigerioVolume:
3
Language:
english
Pages:
4
DOI:
10.1007/bf00368890
Date:
May, 1995
File:
PDF, 334 KB
english, 1995